CoChat

Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities

Open access
Madison, J M, Zhou, F, Nigam, A, Hussain, A, Barker, D D, Nehme, R, van der Ven, K, Hsu, J, Wolf, P, Fleishman, M, O'Dushlaine, C, Rose, S, Chambert, K, Lau, F H, Ahfeldt, T, Rueckert, E H, Sheridan, S D, Fass, D M, Nemesh, J, Mullen, T E, Daheron, L, McCarroll, S, Sklar, P, Perlis, R H, Haggarty, S J · 2015 · Molecular Psychiatry
Cited by 179

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Bipolar disorder (BD) is a common neuropsychiatric disorder characterized by chronic recurrent episodes of depression and mania. Despite evidence for high heritability of BD, little is known about its underlying pathophysiology. To develop new tools for investigating the molecular and cellular basis of BD, we applied a family-based paradigm to derive and characterize a set of 12 induced pluripotent stem cell (iPSC) lines from a quartet consisting of two BD-affected brothers and their two unaffected parents. Initially, no significant phenotypic differences were observed between iPSCs derived from the different family members. However, upon directed neural differentiation, we observed that CXCR4 (CXC chemokine receptor-4) expressing central nervous system (CNS) neural progenitor cells (NPCs) from both BD patients compared with their unaffected parents exhibited multiple phenotypic differences at the level of neurogenesis and expression of genes critical for neuroplasticity, including WNT pathway components and ion channel subunits. Treatment of the CXCR4+ NPCs with a pharmacological inhibitor of glycogen synthase kinase 3, a known regulator of WNT signaling, was found to rescue a progenitor proliferation deficit in the BD patient NPCs. Taken together, these studies provide new cellular tools for dissecting the pathophysiology of BD and evidence for dysregulation of key pathways involved in neurodevelopment and neuroplasticity. Future generation of additional iPSCs following a family-based paradigm for modeling complex neuropsychiatric disorders in conjunction with in-depth phenotyping holds promise for providing insights into the pathophysiological substrates of BD and is likely to inform the development of targeted therapeutics for its treatment and ideally prevention.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mp.2015.7

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 23 references

Research works printed but not linked: 50

  1. Newberg AR, Catapano LA, Zarate CA, Manji HK . Neurobiology of bipolar disorder. Expert Rev Neurother 2008; 8: 93–110. · DOI
  2. Cataldo AM, McPhie DL, Lange NT, Punzell S, Elmiligy S, Ye NZ et al. Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol 2010; 177: 575–585. · DOI · Paper page
  3. Soeiro-de-Souza MG, Dias VV, Figueira ML, Forlenza OV, Gattaz WF, Zarate CA Jr et al. Translating neurotrophic and cellular plasticity: from pathophysiology to improved therapeutics for bipolar disorder. Acta Psychiatr Scand 2012; 126: 332–341. · DOI · Paper page
  4. Mendlewicz J, Rainer JD . Adoption study supporting genetic transmission in manic depressive illness. Nature 1977; 268: 327–329. · DOI · Paper page
  5. Craddock N, Sklar P . Genetics of bipolar disorder. Lancet 2013; 381: 1654–1662. · DOI · Paper page
  6. Phillips ML, Swartz HA . A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am J Psychiatry 2014; 171: 829–843. · DOI · Paper page
  7. Brandon NJ, Sawa A . Linking neurodevelopmental and synaptic theories of mental illness through DISC1. Nat Rev Neurosci 2011; 12: 707–722. · DOI · Paper page
  8. Mao Y, Ge X, Frank CL, Madison JM, Koehler AN, Doud MK et al. Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell 2009; 136: 1017–1031. · DOI · Paper page
  9. Valvezan AJ, Klein PS . GSK-3 and Wnt signaling in neurogenesis and bipolar disorder. Front Mol Neurosci 2012; 5: 1. · DOI · Paper page
  10. O'Brien WT, Klein PS . Validating GSK3 as an in vivo target of lithium action. Biochem Soc Trans 2009; 37: 1133–1138. · DOI · Paper page
  11. Beaulieu JM, Gainetdinov RR, Caron MG . Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 2009; 49: 327–347. · DOI · Paper page
  12. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861–872. · DOI · Paper page
  13. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451: 141–146. · DOI · Paper page
  14. Raya A, Rodriguez-Piza I, Guenechea G, Vassena R, Navarro S, Barrero MJ et al. Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells. Nature 2009; 460: 53–59. · DOI · Paper page
  15. Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008; 321: 1218–1221. · DOI · Paper page
  16. Urbach A, Bar-Nur O, Daley GQ, Benvenisty N . Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 2010; 6: 407–411. · DOI · Paper page
  17. Sheridan SD, Theriault KM, Reis SA, Zhou F, Madison JM, Daheron L et al. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One 2011; 6: e26203. · DOI · Paper page
  18. Park IH, Daley GQ . Human iPS cell derivation/reprogramming. Curr Protoc Stem Cell Biol 2009 8:A:4A.1:4A.1.1-4A.1.8. · DOI
  19. Robicsek O, Karry R, Petit I, Salman-Kesner N, Muller FJ, Klein E et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry 2013; 18: 1067–1076. · DOI · Paper page
  20. Pedrosa E, Sandler V, Shah A, Carroll R, Chang C, Rockowitz S et al. Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells. J Neurogenet 2011; 25: 88–103. · DOI · Paper page
  21. Mostoslavsky G, Kotton DN, Fabian AJ, Gray JT, Lee JS, Mulligan RC . Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol Ther 2005; 11: 932–940. · DOI · Paper page
  22. Park IH, Lerou PH, Zhao R, Huo H, Daley GQ . Generation of human-induced pluripotent stem cells. Nat Protoc 2008; 3: 1180–1186. · DOI · Paper page
  23. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559–575. · DOI · Paper page
  24. Weir BS, Anderson AD, Hepler AB . Genetic relatedness analysis: modern data and new challenges. Nat Rev Genet 2006; 7: 771–780. · DOI · Paper page
  25. Yuan SH, Martin J, Elia J, Flippin J, Paramban RI, Hefferan MP et al. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One 2011; 6: e17540. · DOI · Paper page
  26. Pan JQ, Lewis MC, Ketterman JK, Clore EL, Riley M, Richards KR et al. AKT kinase activity is required for lithium to modulate mood-related behaviors in mice. Neuropsychopharmacology 2011; 36: 1397–1411. · DOI
  27. Gershon ES, Targum SD, Matthysse S, Bunney WE Jr . Color blindness not closely linked to bipolar illness. Report of a new pedigree series. Arch Gen Psychiatry 1979; 36: 1423–1430. · doi:10.1001/archpsyc.1979.01780130041005
  28. Muller FJ, Schuldt BM, Williams R, Mason D, Altun G, Papapetrou EP et al. A bioinformatic assay for pluripotency in human cells. Nat Methods 2011; 8: 315–317. · DOI · Paper page
  29. Koch P, Opitz T, Steinbeck JA, Ladewig J, Brustle O . A rosette-type, self-renewing human ES cell-derived neural stem cell with potential for in vitro instruction and synaptic integration. Proc Natl Acad Sci USA 2009; 106: 3225–3230. · DOI · Paper page
  30. Topark-Ngarm A, Golonzhka O, Peterson VJ, Barrett B Jr, Martinez B, Crofoot K et al. CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene. J Biol Chem 2006; 281: 32272–32283. · DOI · Paper page
  31. Simon R, Brylka H, Schwegler H, Venkataramanappa S, Andratschke J, Wiegreffe C et al. A dual function of Bcl11b/Ctip2 in hippocampal neurogenesis. EMBO J 2012; 31: 2922–2936. · DOI · Paper page
  32. Molyneaux BJ, Arlotta P, Menezes JR, Macklis JD . Neuronal subtype specification in the cerebral cortex. Nat Rev Neurosci 2007; 8: 427–437. · DOI · Paper page
  33. Green EK, Grozeva D, Forty L, Gordon-Smith K, Russell E, Farmer A et al. Association at SYNE1 in both bipolar disorder and recurrent major depression. Mol Psychiatry 2013; 18: 614–617. · DOI
  34. Green EK, Hamshere M, Forty L, Gordon-Smith K, Fraser C, Russell E et al. Replication of bipolar disorder susceptibility alleles and identification of two novel genome-wide significant associations in a new bipolar disorder case–control sample. Mol Psychiatry 2012; 18: 1302–7. · DOI · Paper page
  35. Lage K, Karlberg EO, Storling ZM, Olason PI, Pedersen AG, Rigina O et al. A human phenome–interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol 2007; 25: 309–316. · DOI · Paper page
  36. Zhao WN, Cheng C, Theriault KM, Sheridan SD, Tsai LH, Haggarty SJ . A high-throughput screen for Wnt/beta-catenin signaling pathway modulators in human iPSC-derived neural progenitors. J Biomol Screen 2012; 17: 1252–1263. · DOI · Paper page
  37. Osumi N, Shinohara H, Numayama-Tsuruta K, Maekawa M . Concise review: Pax6 transcription factor contributes to both embryonic and adult neurogenesis as a multifunctional regulator. Stem Cells 2008; 26: 1663–1672. · DOI · Paper page
  38. Suter DM, Tirefort D, Julien S, Krause KH . A Sox1 to Pax6 switch drives neuroectoderm to radial glia progression during differentiation of mouse embryonic stem cells. Stem Cells 2009; 27: 49–58. · DOI · Paper page
  39. Chen HM, DeLong CJ, Bame M, Rajapakse I, Herron TJ, McInnis MG, O'Shea KS . Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients. Transl Psychiatry 2014; 4: e375. · DOI · Paper page
  40. Rush AM, Wittmack EK, Tyrrell L, Black JA, Dib-Hajj SD, Waxman SG . Differential modulation of sodium channel Na(v)1.6 by two members of the fibroblast growth factor homologous factor 2 subfamily. Eur J Neurosci 2006; 23: 2551–2562. · DOI
  41. Lou JY, Laezza F, Gerber BR, Xiao M, Yamada KA, Hartmann H et al. Fibroblast growth factor 14 is an intracellular modulator of voltage-gated sodium channels. J Physiol 2005; 569: 179–193. · DOI · Paper page
  42. Wittmack EK, Rush AM, Craner MJ, Goldfarb M, Waxman SG, Dib-Hajj SD . Fibroblast growth factor homologous factor 2B: association with Nav1.6 and selective colocalization at nodes of Ranvier of dorsal root axons. J Neurosci 2004; 24: 6765–6775. · DOI
  43. Liu CJ, Dib-Hajj SD, Renganathan M, Cummins TR, Waxman SG . Modulation of the cardiac sodium channel Nav1.5 by fibroblast growth factor homologous factor 1B. J Biol Chem 2003; 278: 1029–1036. · DOI · Paper page
  44. Yan H, Pablo JL, Pitt GS . FGF14 regulates presynaptic Ca2+ channels and synaptic transmission. Cell Rep 2013; 4: 66–75. · DOI
  45. Xiao M, Bosch MK, Nerbonne JM, Ornitz DM . FGF14 localization and organization of the axon initial segment. Mol Cell Neurosci 2013; 56: 393–403. · DOI
  46. Shavkunov AS, Wildburger NC, Nenov MN, James TF, Buzhdygan TP, Panova-Elektronova NI et al. The fibroblast growth factor 14.voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3). J Biol Chem 2013; 288: 19370–19385. · DOI · Paper page
  47. Zuko A, Kleijer KT, Oguro-Ando A, Kas MJ, van Daalen E, van der Zwaag B et al. Contactins in the neurobiology of autism. Eur J Pharmacol 2013; 719: 63–74. · DOI · Paper page
  48. Kerner B, Lambert CG, Muthen BO . Genome-wide association study in bipolar patients stratified by co-morbidity. PLoS One 2011; 6: e28477. · DOI
  49. Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, Duka T et al. F3/contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 2003; 115: 163–175. · DOI · Paper page
  50. Haggarty SJ, Perlis RH . Translation: screening for novel therapeutics with disease-relevant cell types derived from human stem cell models. Biol Psychiatry 2013; 75: 952–60. · DOI

Cited by

Metadata

Authors
Madison, J. M., Zhou, F., Nigam, A., Hussain, A., Barker, D. D., Nehme, R., van der Ven, K., Hsu, J., Wolf, P., Fleishman, M., O'Dushlaine, C., Rose, S., Chambert, K., Lau, F. H., Ahfeldt, T., Rueckert, E. H., Sheridan, S. D., Fass, D. M., Nemesh, J., Mullen, T. E., Daheron, L., McCarroll, S., Sklar, P., Perlis, R. H., & Haggarty, S. J.
Venue
Molecular Psychiatry
Published
2015-03-03
Volume
20
Issue
6
Pages
703-717
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2011526626
Cited by
179
References
23
FWCI
9.39
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.